5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...

5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...

5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...

5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...

5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...

5/20/2025Innovent's XNW5004 Receives Breakthrough Therapy Designation

5/20/2025CTTQ Initiates Phase 3 Trial of HER2-Targeting Bispecific ADC TQB2102

5/20/20253SBio Advances SSGJ-707 into Phase 3 Trial for NSCLC

5/20/2025ArkBio Announces Positive Phase II Results of AK3280

5/20/2025SparX and Mitsubishi Tanabe Forge Strategic ADC Research Collaboration

5/20/2025BeiGene Advances BTK Degrader BGB-16673 in Head-to-Head Phase 3 Trial

More>>

5/20/2025'China's Ozempic' may vie with Eli Lilly, Novo Nordisk for global weig...

5/20/2025How Trump's Proposed Price Cuts Could Hurt China's Innovative Drugmake...

5/16/2025US Tariffs on Pharmaceuticals Could Hit Chinese Export Firms’ Profit ...

5/16/2025SMEI: China's Pharmaceutical Industry Seeks Stability and Innovation A...

5/12/2025Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...

5/9/2025China Still Go-To Source for New Drugs Despite Tariff Minefield (BioSp...

5/8/2025Redefining Translational Research and China's Impact on US Drug Develo...

5/5/2025China Introduces A New Regulatory Data Protection And Exclusivity Mech...

5/1/2025Pharma's Crossroads: U.S. Investment Surges Under Trump, While China F...

4/29/2025High Return Rate: Are Chinese Innovative Drugs Facing a "Breakup" Cris...

4/26/2025China Aims for Significant Pharma Industry Digital Transformation by 2...

More>>